UBS Group’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.23M Buy
420,263
+163,639
+64% +$4M ﹤0.01% 3556
2025
Q4
$6.87M Sell
256,624
-55,650
-18% -$1.43M ﹤0.01% 3704
2025
Q3
$8.32M Buy
312,274
+245,440
+367% +$6.34M ﹤0.01% 3499
2025
Q2
$1.53M Sell
66,834
-22,490
-25% -$558K ﹤0.01% 5076
2025
Q1
$2.59M Sell
89,324
-64,418
-42% -$2.06M ﹤0.01% 4470
2024
Q4
$5.71M Buy
153,742
+52,710
+52% +$2.41M ﹤0.01% 3682
2024
Q3
$4.9M Sell
101,032
-21,649
-18% -$950K ﹤0.01% 3093
2024
Q2
$4.91M Buy
122,681
+42,229
+52% +$1.75M ﹤0.01% 2892
2024
Q1
$3.53M Buy
80,452
+9,366
+13% +$484K ﹤0.01% 3350
2023
Q4
$4.4M Buy
71,086
+52,714
+287% +$2.77M ﹤0.01% 2915
2023
Q3
$845K Buy
18,372
+3,524
+24% +$192K ﹤0.01% 4233
2023
Q2
$853K Sell
14,848
-8,142
-35% -$361K ﹤0.01% 4383
2023
Q1
$862K Buy
22,990
+5,916
+35% +$194K ﹤0.01% 4239
2022
Q4
$478K Buy
17,074
+1,624
+11% +$47.2K ﹤0.01% 4748
2022
Q3
$434K Sell
15,450
-12,086
-44% -$395K ﹤0.01% 4463
2022
Q2
$958K Sell
27,536
-353
-1% -$12.6K ﹤0.01% 3775
2022
Q1
$1M Buy
27,889
+14,471
+108% +$410K ﹤0.01% 4094
2021
Q4
$313K Buy
13,418
+4,158
+45% +$85K ﹤0.01% 5340
2021
Q3
$176K Sell
9,260
-21,627
-70% -$424K ﹤0.01% 5415
2021
Q2
$623K Sell
30,887
-11,056
-26% -$208K ﹤0.01% 4561
2021
Q1
$769K Sell
41,943
-1,038
-2% -$19.3K ﹤0.01% 4512
2020
Q4
$865K Buy
42,981
+25,930
+152% +$505K ﹤0.01% 4127
2020
Q3
$320K Sell
17,051
-18,491
-52% -$372K ﹤0.01% 4504
2020
Q2
$798K Buy
35,542
+4,663
+15% +$85.4K ﹤0.01% 3706
2020
Q1
$458K Sell
30,879
-34,585
-53% -$602K ﹤0.01% 4050
2019
Q4
$1.26M Buy
65,464
+1,996
+3% +$38.3K ﹤0.01% 3988
2019
Q3
$1.26M Buy
63,468
+10,632
+20% +$221K ﹤0.01% 3756
2019
Q2
$1.11M Buy
52,836
+10,110
+24% +$211K ﹤0.01% 3671
2019
Q1
$873K Buy
42,726
+28,730
+205% +$644K ﹤0.01% 3685
2018
Q4
$278K Sell
13,996
-1,037
-7% -$20.4K ﹤0.01% 4692
2018
Q3
$289K Buy
15,033
+11,798
+365% +$210K ﹤0.01% 4784
2018
Q2
$49K Sell
3,235
-3,712
-53% -$64.9K ﹤0.01% 5966
2018
Q1
$131K Buy
6,947
+352
+5% +$6.62K ﹤0.01% 5052
2017
Q4
$127K Buy
6,595
+2,030
+44% +$37.9K ﹤0.01% 5210
2017
Q3
$82K Sell
4,565
-2,964
-39% -$48.8K ﹤0.01% 5445
2017
Q2
$134K Sell
7,529
-1,820
-19% -$28.9K ﹤0.01% 4999
2017
Q1
$136K Sell
9,349
-125
-1% -$1.97K ﹤0.01% 4896
2016
Q4
$174K Sell
9,474
-4,226
-31% -$82.2K ﹤0.01% 4901
2016
Q3
$260K Buy
13,700
+6,800
+99% +$123K ﹤0.01% 4362
2016
Q2
$111K Sell
6,900
-12,600
-65% -$178K ﹤0.01% 4954
2016
Q1
$234K Sell
19,500
-1,074
-5% -$12.7K ﹤0.01% 4380
2015
Q4
$292K Buy
20,574
+18,429
+859% +$243K ﹤0.01% 4370
2015
Q3
$25K Buy
2,145
+1,645
+329% +$24.7K ﹤0.01% 6460
2015
Q2
$9K Sell
500
-3,773
-88% -$58.8K ﹤0.01% 7522
2015
Q1
$64K Buy
4,273
+4,044
+1,766% +$54.1K ﹤0.01% 5810
2014
Q4
$3K Buy
+229
New +$2.49K ﹤0.01% 9214

Other funds holding AMPH